A1 Journal article (refereed)
Isolation and characterization of Yersinia phage fMtkYen3-01 (2024)


Goladze, S., Patpatia, S., Tuomala, H., Ylänne, M., Gachechiladze, N., de Oliveira Patricio, D., Skurnik, M., & Sundberg, L.-R. (2024). Isolation and characterization of Yersinia phage fMtkYen3-01. Archives of Virology, 169, Article 226. https://doi.org/10.1007/s00705-024-06149-6


JYU authors or editors


Publication details

All authors or editorsGoladze, Sophia; Patpatia, Sheetal; Tuomala, Henni; Ylänne, Matti; Gachechiladze, Nino; de Oliveira Patricio, Daniel; Skurnik, Mikael; Sundberg, Lotta-Riina

Journal or seriesArchives of Virology

ISSN0304-8608

eISSN1432-8798

Publication year2024

Publication date19/10/2024

Volume169

Article number226

PublisherSpringer Nature

Publication languageEnglish

DOIhttps://doi.org/10.1007/s00705-024-06149-6

Publication open accessOpenly available

Publication channel open accessPartially open access channel

Publication is parallel published (JYX)https://jyx.jyu.fi/handle/123456789/97555


Abstract

Yersinia enterocolitica causes yersiniosis, the third most common gastrointestinal infection in humans throughout Europe. The emergence of multidrug resistance and the lack of effective new antibiotics have drawn attention to phage therapy as a treatment option. Here, we report the complete genome sequence of phage fMtkYen3-01, which infects Y. enterocolitica serotype O:3 strains. This phage has a genome 40,415 bp in length with 45.1% GC content and 49 predicted genes. fMtkYen3-01 infected 9.5% of the 42 Y. enterocolitica strains tested and showed stability at 25–40 °C, as well as pH 5.0–10.0. These results suggest the therapeutic potential of this phage.


KeywordsYersinia bacteriainfectionsantibiotic resistancebacteriophagesphage therapygenomicssequencing


Contributing organizations


Related projects


Ministry reportingYes

VIRTA submission year2024

Preliminary JUFO rating1


Last updated on 2024-16-11 at 20:05